# Impact of Dexmedetomidine on Acute Kidney Injury Following Living Donor Liver Transplantation

> **NCT03522688** · PHASE4 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 214 (actual)

## Conditions studied

- Acute Kidney Injury
- Liver Diseases

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03522688
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-11
- **Primary completion:** 2023-07-14
- **Final completion:** 2024-07-07
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2023-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03522688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03522688, "Impact of Dexmedetomidine on Acute Kidney Injury Following Living Donor Liver Transplantation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03522688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*